glp 1 approved for prediabetes CMC Weight Loss Helps Patients Take Advantage of New Medicare GLP-1 Coverage · Conway Medical Center Patient education tips for GLP-1,
Description
Nausea, constipation, vomiting, and delayed gastric emptying occur in 20-40% of users during the first month, typically resolving within weeks as your body adapts

Temporary holding of GLP-1 RAs is controversial, as it is unsupported by data regarding optimal washout for return of normal gastric emptying and could increase the risk of glycemic instability [12]

The WHO recently recognized obesity defined as a body mass index of 30 or greater as a chronic condition

Some people lose even more weight up to 20% of their starting weight with medications like tirzepatide (Zepbound)
however we cannot establish causality based on these retrospective results and further prospective investigations are needed. In the second study, researchers focused on examining how GLP-1 use might impact the risk of developing osteoporosis, gout, or osteomalacia (bone softening) in people with type 2 diabetes and obesity

Otherwise, none of these medications are going to be effective. There is a big difference in how these can be taken
